Mark Wildgust
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Papers in ⓘ
- Genetics 10
- Chronic Lymphocytic Leukemia Research 9
-
- Lymphoma Diagnosis and Treatment 6
- Co-authors
- Gerald J. Berry (1 shared paper)Alberto Gabizón (1 shared paper)Olga Lyass (1 shared paper)Elias Jabbour (2 shared papers)Juan Luis Steegmann (2 shared papers)Andreas Hochhaus (2 shared papers)Carolina Pavlovsky (2 shared papers)Giuseppe Saglio (2 shared papers)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (4 papers)Nature Medicine (1 paper)Journal of Thoracic Oncology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Mark Wildgust
18 papers receiving 576 citations
Peers
Comparison fields: 5 of 48
- Genetics 352
- Hematology 350
- Rheumatology 179
- Pathology and Forensic Medicine 156
- Oncology 185
Countries citing papers authored by Mark Wildgust
This map shows the geographic impact of Mark Wildgust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wildgust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wildgust more than expected).
Fields of papers citing papers by Mark Wildgust
This network shows the impact of papers produced by Mark Wildgust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wildgust. The network helps show where Mark Wildgust may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Wildgust, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 301 | |
| 2 | 2004 | 93 | |
| 3 | 2017 | 90 | |
| 4 | 2012 | 27 | |
| 5 | 2023 | 16 | |
| 6 | 2020 | 15 | |
| 7 | 2015 | 8 | |
| 8 | 2017 | 7 | |
| 9 | 2018 | 7 | |
| 10 | 2021 | 6 | |
| 11 | 2025 | 5 | |
| 12 | 2019 | 3 | |
| 13 | Overall survival outcomes in patients with mantle-cell lymphoma (MCL) treated with Ibrutinib in a pooled analysis of 370 patients from 3 international open-label studies | 2016 | 2 |
| 14 | 2004 | 2 | |
| 15 | 2014 | 2 | |
| 16 | 2004 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2025 | 0 |
About Mark Wildgust
Mark Wildgust is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 588 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Treatments and Mutations (3 papers), Protein Degradation and Inhibitors (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Genetics (352 citations), Hematology (350 citations), Rheumatology (179 citations), Pathology and Forensic Medicine (156 citations) and Oncology (185 citations). Mark Wildgust has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Gerald J. Berry, Alberto Gabizón, Olga Lyass, Elias Jabbour, Juan Luis Steegmann, Andreas Hochhaus, Carolina Pavlovsky, Giuseppe Saglio, Hagop M. Kantarjian and Concepción Boqué. Their work appears in journals such as Blood, Journal of Clinical Oncology, Nature Medicine, Journal of Thoracic Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.